Fetalix participates in RESOLVE-Health Living Labs
Fetalix participated in the RESOLVE-Health Living Labs programme, developed in partnership with OneVet, under the call “Innovations in Animal Health Living Lab”, supporting early-stage market validation activities for the company’s emerging solution targeting canine low back pain.
Fetalix awarded Women TechEU funding to advance preclinical validation
Fetalix has been awarded €75,000 through the Women TechEU programme, an initiative of the European Commission dedicated to supporting women-led deep-tech startups across Europe.
Expresso highlights Fetalix’s innovative approach to intervertebral disc regeneration
Fetalix has been featured in Expresso in the article “A Costa das Dores”, which explores new perspectives and solutions for pain-related healthcare challenges. The piece highlights Fetalix’s technology and its potential role in advancing treatment options for low back pain.
